Observational analysis shows differential tissue sensitivity to focused ultrasound and microbubbles, highlighting challenges in treating CNS tumors.
This study examined the differential sensitivity of intramedullary spinal cord tumors (IMSCTs) and healthy tissue to focused ultrasound (FUS) and microbubbles in a rat model of IMSCT. F98 glioma cells were injected into spinal cords of F344 rats. FUS (580 kHz, 10 ms bursts, 1 Hz pulse repetition frequency, 40 s) was delivered to tumor and adjacent healthy tissue at varying pressures (0-1.2 MPa) following intravenous injection of microbubbles (1.00 ± 0.85 µm; 2.4 × 107 microbubbles/100 g). Tissues were collected 24 h post-treatment for histological analysis. Healthy tissue exhibited pressure-dependent damage, including significant differences in red blood cell (RBC) extravasation between 0 and 1.2 MPa conditions (0 ± 0 vs 1.73 × 105 ± 2.15 × 105, p = 0.015), hemorrhagic pools, and tissue disintegration. Conversely, the presence of histopathological features in tumors, regardless of pressure, and no significant differences in RBC extravasation areas between exposure conditions suggests no treatment-induced damage at the tested exposures. These findings indicate F98 gliomas are less sensitive to FUS and microbubbles than healthy spinal cord, likely due to reduced vascularity (p < 0.00001 compared to grey matter, p < 0.05 compared to white matter). This finding indicates alternative strategies (e.g. nanodroplets or molecularly-targeted bubbles) must be explored for effectively treating CNS tumors with low vascularity.
No takes yet. Share an insight, caveat, or question.
Mokhlesabadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: